Cargando…

Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021

OBJECTIVES: New Caledonia, a former zero-COVID country, was confronted with a SARS-CoV-2 Delta variant outbreak in September 2021. We evaluate the relative contribution of vaccination, lockdown, and timing of interventions on healthcare burden. METHODS: We developed an age-stratified mathematical mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochida, Noé, Dupont-Rouzeyrol, Myrielle, Moury, Pierre-Henri, Demaneuf, Thibaut, Gourinat, Ann-Clair, Mabon, Sébastien, Jouan, Marc, Cauchemez, Simon, Mangeas, Morgan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423666/
https://www.ncbi.nlm.nih.gov/pubmed/37583482
http://dx.doi.org/10.1016/j.ijregi.2023.06.004
_version_ 1785089499807612928
author Ochida, Noé
Dupont-Rouzeyrol, Myrielle
Moury, Pierre-Henri
Demaneuf, Thibaut
Gourinat, Ann-Clair
Mabon, Sébastien
Jouan, Marc
Cauchemez, Simon
Mangeas, Morgan
author_facet Ochida, Noé
Dupont-Rouzeyrol, Myrielle
Moury, Pierre-Henri
Demaneuf, Thibaut
Gourinat, Ann-Clair
Mabon, Sébastien
Jouan, Marc
Cauchemez, Simon
Mangeas, Morgan
author_sort Ochida, Noé
collection PubMed
description OBJECTIVES: New Caledonia, a former zero-COVID country, was confronted with a SARS-CoV-2 Delta variant outbreak in September 2021. We evaluate the relative contribution of vaccination, lockdown, and timing of interventions on healthcare burden. METHODS: We developed an age-stratified mathematical model of SARS-CoV-2 transmission and vaccination calibrated for New Caledonia and evaluated three alternative scenarios. RESULTS: High virus transmission early on was estimated, with R(0) equal to 6.6 (95% confidence interval [6.4-6.7]). Lockdown reduced R(0) by 73% (95% confidence interval [70-76%]). Easing the lockdown increased transmission (39% reduction of the initial R(0)); but we did not observe an epidemic rebound. This contrasts with the rebound in hospital admissions (+116% total hospital admissions) that would have been expected in the absence of an intensified vaccination campaign (76,220 people or 34% of the eligible population were first-dose vaccinated during 1 month of lockdown). A 15-day earlier lockdown would have led to a significant reduction in the magnitude of the epidemic (-53% total hospital admissions). CONCLUSION: The success of the response against the Delta variant epidemic in New Caledonia was due to an effective lockdown that provided additional time for people to vaccinate. Earlier lockdown would have greatly mitigated the magnitude of the epidemic.
format Online
Article
Text
id pubmed-10423666
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104236662023-08-15 Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021 Ochida, Noé Dupont-Rouzeyrol, Myrielle Moury, Pierre-Henri Demaneuf, Thibaut Gourinat, Ann-Clair Mabon, Sébastien Jouan, Marc Cauchemez, Simon Mangeas, Morgan IJID Reg Coronavirus (COVID-19) Collection OBJECTIVES: New Caledonia, a former zero-COVID country, was confronted with a SARS-CoV-2 Delta variant outbreak in September 2021. We evaluate the relative contribution of vaccination, lockdown, and timing of interventions on healthcare burden. METHODS: We developed an age-stratified mathematical model of SARS-CoV-2 transmission and vaccination calibrated for New Caledonia and evaluated three alternative scenarios. RESULTS: High virus transmission early on was estimated, with R(0) equal to 6.6 (95% confidence interval [6.4-6.7]). Lockdown reduced R(0) by 73% (95% confidence interval [70-76%]). Easing the lockdown increased transmission (39% reduction of the initial R(0)); but we did not observe an epidemic rebound. This contrasts with the rebound in hospital admissions (+116% total hospital admissions) that would have been expected in the absence of an intensified vaccination campaign (76,220 people or 34% of the eligible population were first-dose vaccinated during 1 month of lockdown). A 15-day earlier lockdown would have led to a significant reduction in the magnitude of the epidemic (-53% total hospital admissions). CONCLUSION: The success of the response against the Delta variant epidemic in New Caledonia was due to an effective lockdown that provided additional time for people to vaccinate. Earlier lockdown would have greatly mitigated the magnitude of the epidemic. Elsevier 2023-06-30 /pmc/articles/PMC10423666/ /pubmed/37583482 http://dx.doi.org/10.1016/j.ijregi.2023.06.004 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Coronavirus (COVID-19) Collection
Ochida, Noé
Dupont-Rouzeyrol, Myrielle
Moury, Pierre-Henri
Demaneuf, Thibaut
Gourinat, Ann-Clair
Mabon, Sébastien
Jouan, Marc
Cauchemez, Simon
Mangeas, Morgan
Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021
title Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021
title_full Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021
title_fullStr Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021
title_full_unstemmed Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021
title_short Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021
title_sort evaluating the strategies to control sars-cov-2 delta variant spread in new caledonia, a zero-covid country until september 2021
topic Coronavirus (COVID-19) Collection
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423666/
https://www.ncbi.nlm.nih.gov/pubmed/37583482
http://dx.doi.org/10.1016/j.ijregi.2023.06.004
work_keys_str_mv AT ochidanoe evaluatingthestrategiestocontrolsarscov2deltavariantspreadinnewcaledoniaazerocovidcountryuntilseptember2021
AT dupontrouzeyrolmyrielle evaluatingthestrategiestocontrolsarscov2deltavariantspreadinnewcaledoniaazerocovidcountryuntilseptember2021
AT mourypierrehenri evaluatingthestrategiestocontrolsarscov2deltavariantspreadinnewcaledoniaazerocovidcountryuntilseptember2021
AT demaneufthibaut evaluatingthestrategiestocontrolsarscov2deltavariantspreadinnewcaledoniaazerocovidcountryuntilseptember2021
AT gourinatannclair evaluatingthestrategiestocontrolsarscov2deltavariantspreadinnewcaledoniaazerocovidcountryuntilseptember2021
AT mabonsebastien evaluatingthestrategiestocontrolsarscov2deltavariantspreadinnewcaledoniaazerocovidcountryuntilseptember2021
AT jouanmarc evaluatingthestrategiestocontrolsarscov2deltavariantspreadinnewcaledoniaazerocovidcountryuntilseptember2021
AT cauchemezsimon evaluatingthestrategiestocontrolsarscov2deltavariantspreadinnewcaledoniaazerocovidcountryuntilseptember2021
AT mangeasmorgan evaluatingthestrategiestocontrolsarscov2deltavariantspreadinnewcaledoniaazerocovidcountryuntilseptember2021